Document:

2007 Employee Stock Purchase Plan Offering Document

 EXHIBIT 10.14E 

JAZZ PHARMACEUTICALS PLC 

2007 EMPLOYEE STOCK PURCHASE PLAN 

OFFERING DOCUMENT 
 (JAZZ PHARMACEUTICALS PLC AND DESIGNATED NON-U.S. RELATED CORPORATIONS)

 In this document, capitalized terms not otherwise defined shall have the same definitions of such terms as in the Jazz
Pharmaceuticals plc 2007 Employee Stock Purchase Plan. 
 1. GRANT; OFFERING DATE.

 (a) The Committee hereby authorizes a series of Offerings pursuant to the terms of this Offering document. 

(b) The first Offering hereunder (the “Initial Offering”) shall begin on June 1, 2012 and shall
consist of four (4) Purchase Periods, with the first Purchase Period ending on November 30, 2012, the second Purchase Period ending on May 31, 2013, the third Purchase Period ending on November 30, 2013, and the fourth Purchase
Period ending on May 31, 2014. 
 (c) After the Initial Offering commences, a concurrent Offering shall begin on
December 1, 2012 and each June 1 and December 1 beginning in 2013 over the term of the Plan and shall be approximately twenty-four (24) months in duration. Offerings shall be concurrent, but an Eligible Employee may enroll in
only one Offering at a time. Each Offering shall consist of four (4) Purchase Periods, each of which shall be approximately six (6) months in length ending on or about May 31 and November 30 each year. Except as provided below, a
Purchase Date is the last day of a Purchase Period or of an Offering, as the case may be. 
 (d) Notwithstanding the foregoing:
(i) if any Offering Date falls on a day that is not a Trading Day, then such Offering Date shall instead fall on the next subsequent Trading Day, and (ii) if any Purchase Date falls on a day that is not a Trading Day, then such Purchase
Date shall instead fall on the immediately preceding Trading Day. 
 (e) Prior to the commencement of any Offering, the Board or
Committee may change any or all terms of such Offering and any subsequent Offerings. The granting of Purchase Rights pursuant to each Offering hereunder shall occur on each respective Offering Date unless prior to such date (i) the Board or
Committee determines that such Offering shall not occur, or (ii) no Ordinary Shares remain available for issuance under the Plan in connection with the Offering. 
 (f) Notwithstanding anything in this Section 1 to the contrary, if the Fair Market Value of an Ordinary Share on any Purchase Date during an Offering is less than or equal to the Fair Market Value of
an Ordinary Share on the Offering Date for that Offering, then that Offering shall terminate immediately following the purchase of Ordinary Shares on such Purchase Date. Participants in the terminated Offering automatically shall be enrolled in the
Offering that commences immediately after such Purchase Date. 

 2. ELIGIBLE EMPLOYEES. 

(a) Each Eligible Employee who has been an Employee for a continuous period of at least ten (10) days ending on the Offering Date of
an Offering hereunder and is either (i) an employee of the Company or (ii) an employee of a Related Corporation that is not incorporated in the United States, provided that the Board or Committee has designated the employees of such
Related Corporation as eligible to participate in the Offering, shall be granted a Purchase Right on the Offering Date of such Offering. 
 (b) Each person who first becomes an Eligible Employee during an Offering shall not be granted a Purchase Right under such Offering, but shall be eligible to participate in subsequent Offerings.

 (c) Notwithstanding the foregoing, the following Employees shall not be Eligible Employees or be granted Purchase Rights under
an Offering hereunder: 
 (i) five percent (5%) shareholders (including ownership through unexercised and/or unvested stock
options) as described in Section 5(c) of the Plan; or 
 (ii) Employees in jurisdictions outside of the United States if, as
of the Offering Date of the Offering, the grant of such Purchase Rights would not be in compliance with the applicable laws of any jurisdiction in which the Employee resides or is employed. 
 3. PURCHASE RIGHTS. 
 (a) Subject to the
limitations herein and in the Plan, a Participant’s Purchase Right shall permit the purchase of the number of Ordinary Shares purchasable with up to fifteen percent (15%) of such Participant’s Earnings paid during the period of such
Offering beginning immediately after such Participant first commences participation; provided, however, that no Participant may have more than fifteen percent (15%) of such Participant’s Earnings applied to purchase Ordinary Shares
under all ongoing Offerings under the Plan and all other plans of the Company and Related Corporations that are intended to qualify as Employee Stock Purchase Plans. 
 (b) For Offerings hereunder, “Earnings” means the base compensation paid to a Participant, including all salary, wages (including amounts elected to be deferred by such
Participant, that would otherwise have been paid, under any cash or deferred arrangement or other deferred compensation program established by the Company or a Related Corporation), but excluding all of the following: all overtime pay, commissions,
bonuses, and other remuneration paid directly to such Participant, profit sharing, the cost of employee benefits paid for by the Company or a Related Corporation, education or tuition reimbursements, imputed income arising under any Company or
Related Corporation group insurance or benefit program, traveling expenses, business and moving expense reimbursements, income received in connection with stock options and other equity awards, contributions made by the Company or a Related
Corporation under any employee benefit plan, and other similar items of compensation. 
 (c) Notwithstanding the foregoing, the
maximum number of Ordinary Shares that a Participant may purchase on any Purchase Date in an Offering shall be such number of Ordinary Shares as has a Fair Market Value (determined as of the Offering Date for such Offering) equal

 
to (x) US$25,000 multiplied by the number of calendar years in which the Purchase Right under such Offering has been outstanding at any time, minus (y) the Fair Market Value of any
other Ordinary Shares (determined as of the relevant Offering Date with respect to such Ordinary Shares) that, for purposes of the limitation of Section 423(b)(8) of the Code, are attributed to any of such calendar years in which the Purchase
Right is outstanding. The amount in clause (y) of the previous sentence shall be determined in accordance with regulations applicable under Section 423(b)(8) of the Code based on (i) the number of Ordinary Shares previously purchased
with respect to such calendar years pursuant to such Offering or any other Offering under the Plan, or pursuant to any other Company or Related Corporation plans intended to qualify as Employee Stock Purchase Plans, and (ii) the number of
Ordinary Shares subject to other Purchase Rights outstanding on the Offering Date for such Offering pursuant to the Plan or any other such Company or Related Corporation Employee Stock Purchase Plan. 

(d) The maximum aggregate number of Ordinary Shares available to be purchased by all Participants under an Offering shall be the number
of Ordinary Shares remaining available under the Plan on the Offering Date, rounded down to the nearest whole Ordinary Share. If the aggregate purchase of Ordinary Shares upon exercise of Purchase Rights granted under all concurrent Offerings under
the Plan would exceed the maximum aggregate number of Ordinary Shares available, the Board or Committee shall make a pro rata allocation of the Ordinary Shares available in an equitable manner. Any Contributions not applied to the purchase of
available Ordinary Shares shall be refunded to the Participants without interest. 
 (e) Notwithstanding the foregoing, the
maximum number of Ordinary Shares that may be purchased on any single Purchase Date by all Eligible Employees under all ongoing Offerings under the Plan shall not exceed 175,000 Ordinary Shares for all Purchase Periods beginning on or after
June 1, 2012. If the aggregate number of Ordinary Shares to be purchased upon the exercise of all outstanding Purchase Rights under the Plan on a single Purchase Date would exceed the limit set forth above, the Board or Committee shall make a
uniform and equitable allocation of the Ordinary Shares available. Any Contributions not applied to the purchase of available Ordinary Shares shall be refunded to the Participants without interest. 

(f) In addition, for the Initial Offering beginning on June 1, 2012 and all subsequent Offerings, the maximum amount of Earnings
that an Eligible Employee may contribute during any Purchase Period shall not exceed US$15,000 (or the local currency equivalent, as determined by the Company). 
 4. PURCHASE PRICE. 
 The purchase price of
Ordinary Shares under an Offering shall be the lesser of: (i) eighty-five percent (85%) of the Fair Market Value of such Ordinary Shares on the Offering Date, or (ii) eighty-five percent (85%) of the Fair Market Value of such
Ordinary Shares on the applicable Purchase Date, in each case rounded up to the nearest whole cent per Ordinary Share; provided, however, that in all cases the purchase price is not less than the nominal value of an Ordinary Share on the
applicable Purchase Date. 

 5. PARTICIPATION. 

(a) An Eligible Employee may elect to participate in an Offering with such election to be effective on the Offering Date. An Eligible
Employee may enroll in only one Offering at a time. An Eligible Employee shall elect his or her payroll deduction percentage on such enrollment form as the Company provides. The completed enrollment form must be delivered to the Company at least ten
(10) days prior to the date participation is to be effective, unless a later time for filing the enrollment form is set by the Company for all Eligible Employees with respect to a given Offering. For clarification, except as provided in
Section 1(f), if an Eligible Employee fails to submit an enrollment form prior to the start of an Offering in which such Eligible Employee is eligible to participate, such Eligible Employee shall be deemed to have withdrawn from such Offering.
Payroll deduction percentages must be expressed in whole percentages of Earnings, with a minimum percentage of one percent (1%) and a maximum percentage of fifteen percent (15%). Except as provided in Section 5(e), a Participant may
participate only by way of payroll deductions. 
 (b) A Participant may increase or decrease his or her participation level at
any time with such change to be effective commencing as of the next Offering in which such Participant is eligible to participate. Any such increase or decrease in participation level shall be made by delivering a notice to the Company or a
designated Related Corporation in such form as the Company provides prior to the ten (10) day period (or such shorter period of time as determined by the Company and communicated to Participants) immediately preceding the next Offering Date for
which it is to be effective and in which such Participant is eligible to participate. A Participant may also increase or decrease his or her participation level to be effective in a subsequent Purchase Period of an ongoing Offering in accordance
with procedures established by the Company. 
 (c) A Participant may increase his or her participation level once during a
Purchase Period. In addition, a Participant may decrease (including a decrease to zero percent (0%)) his or her participation level no more than twice during a Purchase Period (and the second decrease in participation level must be to zero percent
(0%)). Notwithstanding the foregoing or any other provision of this Offering Document or of the Plan to the contrary, the Company may determine in its sole discretion at any time, including at any time following the commencement of an Offering or
Purchase Period, that it will no longer accept Participant requests to increase participation levels during such Offering or Purchase Period, as applicable. For example, any Participant who has not increased his or her payroll deduction level from
zero percent (0%) to at least one percent (1%) by the enrollment form delivery deadline prescribed before the start of a new Offering in which such Participant is eligible to participate, excluding a new Offering commencing pursuant to
Section 1(f), shall be deemed to have withdrawn from the Plan effective as of the first day of that new Offering. Any such change in participation level shall be made by delivering a notice to the Company or a designated Related Corporation in
such form as the Company provides prior to the ten (10) day period (or such shorter period of time as determined by the Company and communicated to Participants) immediately preceding the payroll date for which it is to be effective and such
change will become effective as soon as administratively practicable following the Company’s receipt of the notice. 
 (d)
A Participant may withdraw from an Offering and receive a refund of his or her Contributions (reduced to the extent, if any, such Contributions have been used to acquire Ordinary Shares for the Participant on any prior Purchase Date) without
interest, at any time prior to the end of the Offering, excluding only each ten (10)-day period immediately preceding a Purchase Date (or such shorter period of time determined by the Company and communicated to Participants), by delivering a
withdrawal notice to the Company or a designated Related Corporation in such form as the Company provides. A Participant who has withdrawn from an Offering shall not again participate in such Offering, but may participate in subsequent Offerings
under the Plan in accordance with the terms of the Plan and the terms of such subsequent Offerings. 

 (e) Notwithstanding the foregoing or any other provision of this Offering document or of the
Plan to the contrary, neither the enrollment of any Eligible Employee in the Plan nor any forms relating to participation in the Plan shall be given effect until such time as a registration statement covering the Ordinary Shares reserved under the
Plan that are subject to the Offering has been filed by the Company and has become effective. If the provisions of this Section are applicable, the Company shall establish such procedures as will enable the purposes of the Plan to be satisfied while
complying with applicable securities laws. Such procedures may include, for example, allowing Participants to participate other than by means of payroll deduction and/or allowing Participants to increase their level of participation during a
Purchase Period. 
 (f) Except as provided otherwise in Section 1(f), an Eligible Employee must affirmatively enroll and
authorize payroll deductions in each Offering in which the Eligible Employee elects to participate. 
 6. PURCHASES.

 Subject to the limitations contained herein, on each Purchase Date, each Participant’s Contributions (without any
increase for interest) shall be applied to the purchase of whole Ordinary Shares, up to the maximum number of Ordinary Shares permitted under the Plan and the Offering. 
 7. NOTICES AND AGREEMENTS. 

Any notices or agreements provided for in an Offering or the Plan shall be given in writing, in a form provided by the Company (including
documents delivered in electronic form, if authorized by the Committee), and unless specifically provided for in the Plan or this Offering, shall be deemed effectively given upon receipt or, in the case of notices and agreements delivered by mail by
the Company, fourteen (14) days after deposit in the United States mail, postage prepaid. 
 8. EXERCISE
CONTINGENT ON SHAREHOLDER APPROVAL. 
 The Purchase Rights
granted under an Offering are subject to the approval of the Plan by the shareholders of the Company as required for the Plan to obtain treatment as an Employee Stock Purchase Plan. 
 9. CAPITALIZATION ADJUSTMENTS. 
 The
limitation set forth in Section 3(e) shall be adjusted, as appropriate, to reflect Capitalization Adjustments. 

 10. OFFERING SUBJECT TO PLAN. 

Each Offering is subject to all the provisions of the Plan, and the provisions of the Plan are hereby made a part of the Offering. The
Offering is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of an Offering and those of the
Plan (including interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan), the provisions of the Plan shall control. 
 Adopted by the Compensation Committee of the Board of Directors of Jazz Pharmaceuticals plc on April 24, 2012.Offer Letter from Jazz Pharmaceuticals, Inc.

 Exhibit 10.19 
 January 13, 2012 
 Ms. Suzanne Sawochka Hooper 

Via Email 
  

	Re:	Offer of Employment with Jazz Pharmaceuticals, Inc. 

 Dear Suzanne, 
 I am very pleased to invite you to join Jazz Pharmaceuticals, Inc.
(“Jazz Pharmaceuticals”) and, following the closing of the transaction with Azur Pharma, Jazz Pharmaceuticals plc. This letter sets out the basic terms of your employment with Jazz Pharmaceuticals. 

1. Duties and Responsibilities: Effective March 12, 2012, you will be an employee of Jazz Pharmaceuticals, Inc. and your assignment
will be as an executive officer (subject to approval by the Board of Directors at its February 2012 meeting) and General Counsel of Jazz Pharmaceuticals plc, reporting to Bruce Cozadd, Chairman & Chief Executive Officer. Between the date of
commencement of your employment and March 12, 2012 you will be an employee of Jazz Pharmaceuticals, Inc. with such duties and responsibilities as are determined by Mr. Cozadd. This offer is for a full time position. The position may
require you to travel from time to time to other locations as may be necessary to fulfill your responsibilities. As part of your employment relationship, you agree to comply with Jazz Pharmaceuticals’ policies and procedures in effect from time
to time during your employment. 
 2. Salary and Bonus: Your initial annual base salary will be $465,000, payable in accordance
with Jazz Pharmaceuticals’ customary payroll practices, for all hours worked. Salary is subject to periodic review and adjustment by Jazz Pharmaceuticals, in accordance with its normal practices. The Company has a cash bonus plan under which
annual bonuses may be given based on the Company meeting its annual objectives, and each employee’s meeting of his or her objectives. Your bonus target will be 50% of salary paid during the calendar year. Whether there will be a bonus in
any year, and the size of any bonus if there is one, is within the discretion of the Board of Directors. 
 3. Additional Bonus:
Jazz Pharmaceuticals will pay you a one time cash bonus of $125,000 payable on the first regular pay day after March 12, 2012, in accordance with customary payroll practices. Subject to your continued employment in good standing, you will be
paid a cash bonus of $62,500 payable on the closest pay date after 6 months of continued employment and an additional cash bonus of $62,500 on the closest pay date after 12 months of continued employment. In each case bonuses will be paid in
accordance with then current customary payroll practices.  

 4. Benefits: You generally will be eligible to receive all benefits which are extended
to other similarly-situated employees at Jazz Pharmaceuticals, including medical and dental benefits, life insurance and other benefits offered to regular employees. You will be eligible for paid time off and holidays in accordance with Jazz
Pharmaceuticals’ policies. As a Corporate Officer, you will be a participant in the company’s Amended and Restated Executive Change of Control and Severance Benefit Plan. 
 5. Confidential Information; Employee Confidential Information and Inventions Agreement: To enable Jazz Pharmaceuticals to safeguard its proprietary and confidential information, it is a
condition of employment that you sign Jazz Pharmaceuticals’ standard form of “Employee Confidential Information and Inventions Agreement.” We understand that you are likely to have signed similar agreements with prior employers, and
wish to impress upon you that Jazz Pharmaceuticals does not want to receive the confidential or proprietary information of others, and will support you in respecting your lawful obligations to prior employers. By accepting this offer, you are
representing to Jazz Pharmaceuticals that your performance of your duties will not violate any agreements you may have with, or trade secrets of, any third parties. You agree that, during your employment with Jazz Pharmaceuticals, you will not
engage in any business activity that competes with Jazz Pharmaceuticals, and you will notify your supervisor if you are considering accepting outside work. 
 6. Code of Conduct: Jazz Pharmaceuticals is committed to integrity and the pursuit of excellence in all we do. We fulfill these commitments while upholding a
high level of ethical conduct. The Code of Conduct (enclosed) is one element of Jazz Pharmaceuticals’ efforts to ensure lawful and ethical conduct by the company and its subsidiaries and their employees, officers and directors. It is
a condition of employment that you read, agree to and sign the enclosed form certifying that you will abide by Jazz Pharmaceuticals’ Code of Conduct by the time you begin active employment at Jazz Pharmaceuticals. If you have questions
about the Code of Conduct, please let Human Resources know and we will ensure that you receive answers to your inquiries as quickly as possible. 
 7. At-Will Employment: Should you decide to accept our offer, you will be an “at-will” employee of Jazz Pharmaceuticals. This means that either you or Jazz Pharmaceuticals
may terminate the employment relationship with or without cause at any time. Participation in any benefit, compensation or bonus program does not change the nature of the employment relationship, which remains “at-will”. 

8. Authorization to Work: Federal government regulations require that all prospective employees present documentation verifying
their identity and demonstrating that they are authorized to work in the United States. If you have any questions about this requirement, which applies to U.S. citizens and non-U.S. citizens alike, please contact Heather McGaughey, our Vice
President, Human Resources. Your employment is contingent on your ability to prove your identity and authorization to work in the United States, and your complying with the government’s employment verification requirements. 

 9. Background Check: This offer is contingent on the successful completion of a
background check in compliance with Jazz Pharmaceuticals’ SOX practices. 
 10. Complete Offer and Agreement:
This letter contains our complete understanding and agreement regarding the terms of your employment by Jazz Pharmaceuticals. There are no other, different or prior agreements or understandings on this or related subjects. Changes to the terms of
your employment can be made only in a writing signed by you and the Chief Executive Officer of Jazz Pharmaceuticals, although it is understood that as part of the policy of employment at will, Jazz Pharmaceuticals may, from time to time, in its sole
discretion, adjust your salary, incentive compensation and benefits, as well as your job title, location, duties, responsibilities, assignments and reporting relationships. 
 11. Acceptance of Offer: We look forward to your acceptance of this offer and hope you will begin your full-time employment at Jazz Pharmaceuticals soon. If our offer is
acceptable to you, please sign the enclosed copy of this letter in the space indicated and return it to me no later than January 20, 2012. 

12. Severability: If any provision of this offer is held to be invalid, void or unenforceable, the remainder of
the agreement set forth herein will remain unaffected, and you and Jazz Pharmaceuticals will work together to achieve the intent of the affected provisions. 
 Suzanne, our team is impressed by your accomplishments and potential, and we are enthusiastic at the prospect of your joining us. I look forward to your early acceptance of this offer, and to your
contributions to the growth and success of Jazz Pharmaceuticals. 
 Sincerely, 
 /s/ Bruce Cozadd 
 Bruce Cozadd 
 Chief Executive Officer 
 ACCEPTANCE OF EMPLOYMENT OFFER: 

I accept the offer of employment by Jazz Pharmaceuticals, Inc. on the terms described in this letter. 

Signature:     /s/ Suzanne
Hooper                 
 Date: 1/19/12 

My start date will be February 6, 2012, expected. To be confirmed.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]